tissue artifacts on frozen sections frequently complicates precise determination of the histopathological tumor grade. Therefore, additional methods for rapid and reliable analysis of biopsy samples are highly desirable.
To facilitate the characterization of resected tissue during brain tumor surgery, our group developed an original technique of iFC. Our objective in the present study was to evaluate the feasibility of this method during resection of intracranial gliomas and to assess its diagnostic efficacy for rapidly determining tumor presence in a biopsy specimen and its WHO histopathological grade.
Methods
Our original technique of iFC of surgical biopsy samples was applied during the resection of 100 intracranial neoplasms. All procedures were performed in the Department of Neurosurgery at the Tokyo Women's Medical University between January 2009 and August 2010. Data were prospectively collected in a constantly maintained computer database. According to the objectives of the present study, 83 tumors with a final histopathological diagnosis of WHO Grade II, III, or IV glioma of astrocytic, oligodendroglial, oligoastrocytic, or ependymal origin were selected for analysis. Two cases were later eliminated from the investigated cohort: the lesion in one case was a recurrent anaplastic astrocytoma, which had been previously subjected to high-dose radiotherapy, whereas the lesion in a second case was a disseminated glioblastoma whose neoplastic cells were microscopically identified exclusively in the subpial regions, and only reactive astrocytes were revealed in brain parenchyma. It was believed that in both of these cases the determination of histopathological tumor grade and/or evaluation of DNA content using iFC could lead to erroneous results. The remaining 81 cases constituted the clinical and histopathological basis of our study and included 67 newly diagnosed and 14 recurrent neoplasms.
Pathological tissue samples were obtained during surgery in 47 men (mean age 44.7 ± 17.2 years) and 34 women (mean age 42.3 ± 15.0 years). The requirement for enrollment was negative preoperative testing for hepatitis B, hepatitis C, HIV, syphilis, parvovirus, and human T-lymphotropic virus. The research protocol was approved by the local ethics committee. Each patient agreed to participate in the study and provided signed informed consent.
Tissue Sampling
Analyzed pathological tissue was sampled from the specific area of interest using forceps under the control of updated neuronavigation based on intraoperative MRI. 15 In total, 328 separate biopsy specimens were taken during the resection of 81 gliomas. Each specimen had a volume of around 3-6 mm 3 and was separated into 3 more or less equal parts with a volume of 1-2 mm 3 each: 1) 1 piece for iFC analysis; 2) 1 piece for intraoperative histopathological examination on frozen sections; and 3) 1 piece for permanent histopathological investigation on formalin-fixed paraffin-embedded tissue sections. Usually the central part of the specimen was analyzed with iFC, whereas its peripheral parts were sent for histopathological investigation.
Intraoperative Flow Cytometry Analysis
For iFC analysis investigated tissue was placed in a test tube containing 2 ml of mixed reagent consisting of 0.25 ml/ml Triton X-100 in PBS (Kishida Chemical Co., Ltd.), 0.25 mg/ml RNase in PBS (Sigma-Aldrich Co., LLC), 0.05 mg/ml propidium iodide in PBS (Sigma-Aldrich Co., LLC), and PBS (Kishida Chemical Co., Ltd.). The analyzed tissue was disrupted by pipetting for 200 seconds. After confirming that the tissue sample was sufficiently homogenized, it was isolated by pipetting, and cell nuclei were stained with interfacial action agents at room temperature under protection from light for 5 minutes. After that the suspension was filtered by 50-mm mesh nylon, and the measurement of DNA content was started 1 minute later. Human peripheral blood mononuclear cells were stained in the same way to be used as a reference during DNA histogram analysis.
Evaluation of DNA content was done with an EPICS flow cytometer (Beckman Coulter, Inc.). After excitation with a 488-nm laser, the fluorescence of 610 ± 10 nm was checked and measured for 4 minutes at a low sample flow rate (15 ml/minute). The intensity of the fluorescent peak of the stained human peripheral blood mononuclear cells was fixed on the DNA histogram under the scale value of 200. Several areas on the histogram were defined according to the predominance of a specific cell type. Sub-G 0 G 1 phase cells, apoptotic cells, and debris corresponded to Area A, G 0 G 1 phase (diploid) cells to Area B, S phase cells to Area C, aneuploid cells with an abnormal number of chromosomes to Area D, G 2 /M phase cells to Area E, and cells containing more DNA than G 2 /M phase cells to Area F (Fig. 1) . Thereafter, the malignancy index (MI) was determined as the ratio of the number of cells with greater than normal DNA content to the total number of cells (N), that is: MI = (Area C + Area D + Area E + Area F)/N. If DNA aneuploidy was detected, the DNA index was also calculated as the ratio of DNA content in the aneuploid cells with an abnormal number of chromosomes (Area D) to those in G 0 G 1 cells (Area B). If the cells could not be distinguished from the G 2 /M phase of diploid cells (DNA index > 1.95), they were not considered aneuploid.
Histopathological Investigation
Histopathological investigation of the tissue samples on both frozen and permanent tissue sections was performed by the sole board-certified pathologist with subspecialization in neuropathology (T.K.).
Intraoperative histopathological examination of the frozen tissue sections using H & E staining was mainly directed at identifying tumor presence and its approximate degree of malignancy (low grade vs high grade). Final histopathological diagnosis based on the latest criteria of the WHO 13 was established on the formalin-fixed paraffin-embedded tissue sections stained with H & E and appropriate antibodies for immunohistochemistry. It was used as a "gold standard" for evaluation of the diagnostic efficacy of iFC analysis of the tissue sample. Obtained specimens of peritumoral brain without identifiable neoplastic cells were considered as normal controls.
Statistical Analysis
The Student t-test was applied for comparison of the MI between normal and tumor tissues for each WHO histopathological grade. To evaluate the diagnostic efficacy of the MI in discriminating normal brain tissue and various WHO histopathological grades of glioma, ROC curve analysis was done by calculating the AUC. Of note, an AUC value of 1 denotes a perfect test, whereas a value of 0.5 shows complete lack of discrimination. The Youden index was used to calculate the optimal cutoff value for the MI.
1, 11 The occurrence of DNA aneuploidy in tumors with different WHO histopathological grades was compared using the chi-square test. One-way ANOVA was used to determine the differences for the MI and DNA index in tumors with different WHO histopathological grades. Additionally, the Tukey HSD test was performed to identify significant differences between each group of neoplasms. The level of statistical significance was defined at p < 0.05.
Results
Histopathological investigation of the formalin-fixed paraffin-embedded tissue sections revealed 29 WHO Grade II tumors (11 diffuse astrocytomas, 8 oligodendrogliomas, 9 oligoastrocytomas, and 1 ependymoma), 23 WHO Grade III tumors (7 anaplastic astrocytomas, 8 anaplastic oligodendrogliomas, 6 anaplastic oligoastrocytomas, and 2 anaplastic ependymomas), and 29 WHO Grade IV glioblastomas. In none of the cases did we identify a discrepancy in the results as relates to the identification of tumor presence on frozen tissue sections as compared with permanent sections.
The MI of resected gliomas differed significantly from specimens of perilesional brain without histopathologically identifiable tumor (25.3% ± 22.0% vs 4.6% ± 2.6%, p < 0.01, Student t-test). The diagnostic efficacy of iFC using various cutoff values of the MI to discriminate between neoplastic tissue and perilesional brain is outlined in Table 1 . The ROC analysis revealed a corresponding AUC value of 0.941 (Fig. 2) . The optimal cutoff value for the MI, identified with the Youden index, was 6.8%. It provided 0.88 sensitivity, 0.88 specificity, 0.97 positive predictive value, 0.60 negative predictive value, and 0.88 diagnostic accuracy.
The MI showed a direct association with the histopathological grade of the tumor. Its corresponding values in WHO Grade II, III, and IV gliomas were 13.3% ± 11.0%, 35.0% ± 21.8%, and 46.6% ± 23.1%. The differences in MI between all investigated groups of neoplasms were statistically significant (p < 0.01, ANOVA), but the values overlapped prominently (Fig. 3) . The typical DNA histogram pattern also showed an association with the WHO histopathological grade of the tumor (Fig. 4) .
Meanwhile, neither the frequency of DNA aneuploidy nor the DNA index differed significantly between the different groups of tumors. Specifically, DNA aneuploidy was observed in 10 (34.5%) of 29 WHO Grade II tumors, 11 (47.8%) of 23 WHO Grade III tumors, and 17 (58.6%) of 29 WHO Grade IV tumors (p = 0.70, chi-square test). The mean DNA index of WHO Grade II, III, and IV gliomas was 1.67 ± 0.21, 1.58 ± 0.33, and 1.60 ± 0.39, respectively (p = 0.46, ANOVA).
The duration of iFC analysis varied from 9 to 10 minutes (mean 9.5 minutes). The duration of the intraoperative histopathological examination of frozen sections was approximately 20 minutes.
Illustrative Case
A 32-year-old man presented with mesial temporal lobe epilepsy poorly controlled with medication. There were no other neurological symptoms or signs. His general condition was good and his Karnofsky Performance Scale score was 90. An intraaxial hyperintense lesion was demonstrated in the medial part of the left temporal lobe on T2-weighted MRI. There was neither contrast enhancement on MRI nor methionine uptake on PET scanning (Fig. 5) . The differential diagnosis considered either low-grade glioma or cortical dysplasia. During surgery, open biopsy from the center of the lesion was performed under the guidance of updated neuronavigation based on intraoperative MRI. However, histopathological investigation of the frozen sections did not reveal neoplastic pathology. At the same time iFC analysis disclosed an MI of 39.9% with clear detection of aneuploid cells on the DNA histogram. Aggressive resection of the lesion was performed given the strong suspicion of tumor, and the final histopathological diagnosis established on permanent tissue sections revealed diffuse astrocytoma (WHO Grade II).
Discussion
Microscopic investigation of pathological material on frozen tissue sections represents the gold standard for intraoperative histopathological diagnosis. However, this technique has several important limitations. First, it is time-consuming, typically requiring around 20-30 minutes for tissue processing and staining, unless the pathology laboratory is located within the operating block itself. Second, interpretation of the microscopic data varies between individual pathologists, and the reliability of the established diagnosis is strongly related to their experience and skill. Third, appropriateness of the technique of tissue preparation is very important. 18, 21, 24 While in the present series we did not identify any case with a significant discrepancy between histopathological investigation on the frozen versus permanent tissue sections, the reported risk of such discordance varies from 2.7% to 12.4%. 17, 19, 21, 24 To facilitate intraoperative histopathological diagnosis on frozen sections, several specific techniques, such as direct immunofluorescence, 8 ultrarapid immunostaining, 5 and confocal microscopy, 4 have been proposed. It was recently demonstrated that iFC can also be used for such purposes.
14 The method introduced by Mesiwala et al.
14 is based on the use of ultrasound aspiration for the removal and homogenization of pathological tissue with subsequent staining and in situ automatic measurement of DNA content. However, its practical application may lead to erroneous results because of limited precision in tissue sampling and possible mixing of neoplastic and normal brain elements.
To improve the usefulness of iFC in cases of brain tumor resection, our group developed an original analytical method for evaluating DNA content, which is presented herein. It significantly simplifies preprocessing preparation of the tissue sample and tremendously shortens the duration of analysis, which can be completed within 10 minutes. In our experience, it is approximately 2 times faster than intraoperative histopathological examination of the tissue specimen on frozen sections. The shorter period of time required for iFC was attributable to the special setup of the site, which was, in fact, rather simple. The technique is directed on the evaluation of the variety of cells isolated by pipetting under the same conditions. Certainly, it does not permit the separation of neoplastic cells from normal ones, which may result in impaired sensitivity of the analysis. Nevertheless, in the present study the results of iFC correlated well with the histopathological evaluation of permanent formalin-fixed paraffin-embedded tissue sections. The minimal volume of tissue required for iFC is approximately 1-2 mm 3 , which allows the surgeon to very precisely determine the biopsy area both within the bulk of the tumor and at its border.
In general, benign intracranial neoplasms have higher diploid cell numbers, whereas aneuploidy is detected in 30%-80% of high-grade gliomas. 3, 6, 9 Nevertheless, even in glioblastoma various patterns of DNA content can be observed; therefore, it might be inaccurate to determine the histopathological grade of the tumor based only on the presence of aneuploid cells. 6, 16 In our analysis the differences in the frequency of aneuploidy and the DNA index in gliomas of various degrees of malignancy did not reach the level of statistical significance. Therefore, these parameters have limited effectiveness for the intraoperative determination of brain tumor grade.
The main parameter investigated on the DNA histogram was designated as the MI, which should not be confused with the well-known mitotic index. The term "malignancy index" was chosen, since it reflects the known correlation of the proportion of cells in the S and G 2 /M phases with the degree of brain tumor malignancy. 9 Meanwhile, calculation of the MI considers not only cells in the S and G 2 /M phases, but also aneuploid cells with an abnormal number of chromosomes as well as cells containing more DNA than G 2 /M phase cells (DNA index > 1.95). While the latter cells could not be unambiguously considered aneuploid, it is rather difficult to make a precise differentiation. Since simplicity and speed were considered to be required parameters for iFC, the proposed method of MI calculation seems sufficiently suitable for clinical needs.
Distinguishing between reactive astrocytosis and lowgrade glial neoplasm is considered to be one of the most difficult challenges in surgical neuropathology. 17 Our results demonstrate that the MI, as determined using iFC, may be rather effective for identifying glioma presence in a surgical biopsy sample. We determined the optimal cutoff level of 6.8% to discriminate between neoplasm and perilesional brain, whereas greater cutoff levels would further increase the specificity of the analysis. The usefulness of the technique was clearly shown in the illustrative case. Therefore, it seems that the addition of iFC to routine intraoperative histopathological investigation of frozen sections may significantly facilitate the decision-making process during resection of intracranial glioma and may be helpful for monitoring the completeness of tumor removal. It should be emphasized that the proposed method is based on rather strict criteria and allows one to avoid the "subjectivity" of tissue characterization. At the same time, at least at present, iFC definitely cannot replace standard methods of intraoperative histopathological diagnosis, such as the analysis of frozen tissue sections, and should be used only as an adjunctive tool.
In the present series the MI and DNA histogram pattern showed a statistically significant association with the WHO histopathological grade of glioma. However, the overlap of values between tumors of different degrees of malignancy was too prominent. This may have been caused by several factors. First, some spatial differences, while rather small, had existed between samples taken for histopathological investigation and those taken for iFC analysis. Second, nearly all groups of tumors with the same WHO histopathological grade were rather heterogeneous in their origin (astrocytic, oligodendroglial, oligoastrocytic, or ependymal), whereas tumor type might influence DNA content. Third, the variability of the MI might reflect the different biological behaviors of the lesion and/or its propensity for malignant transformation. In any case, this issue may have significant impact on the effective use of iFC and requires clarification in further studies.
There are several limitations to the present study. First, it was performed at a single institution, and all histopathological investigations were done by only one pathologist. It does not permit evaluation of the interobserver variability of obtained results. Second, a blind comparison between iFC analysis and intraoperative histopathological investigation of frozen tissue sections was not performed, and, in fact, both methods were used simultaneously. Therefore, the diagnostic advantages of one method over another and the impact of iFC on surgical decision making during resection of glioma remain generally obscured. Third, smear tissue sections and touch preparations are not routinely used in our clinic. Those techniques may be more effective than investigations of frozen sections and, in fact, may be completed within the same period as iFC. Finally, peritumoral brain tissue without identifiable neoplastic elements was used as a "normal" control. It might be more reliable to establish the standard MI values with iFC analysis of the brain tissue samples in the absence of neoplastic pathology (for example, during epilepsy surgery) and this should be done in the future.
Conclusions
Our original method of iFC with the determination of the MI seems technically feasible and reliable for the rapid determination of glioma presence in a surgical biopsy sample. On the other hand, it may be less useful for detailed characterization of the tumor because of prominent overlap of the MI between neoplasms with different histopathological grades. The cell processing algorithm we developed allows one to complete the analysis within approximately 10 minutes and requires a minimal amount 
